Mittlere Rheinbrücke – Straßenkarte

FarmaceutykiLonza Group AG

↗

Lonza Group AG, founded in 1897, is a Swiss multinational company specializing in contract development and manufacturing services for the pharmaceutical, biotechnology, and nutrition industries. Headquartered in Basel, Switzerland, Lonza operates over 30 sites across Europe, North America, and Asia, employing approximately 18,000 people. The company offers a comprehensive range of services, including the development and manufacturing of biopharmaceuticals, small molecules, cell and gene therapies, and health ingredients. Lonza's mission is to transform customers' breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. The company is recognized as a pioneer and world leader in the contract development and manufacturing organization (CDMO) industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. In 2023, Lonza reported revenues of CHF 3.6 billion and a CORE EBITDA of CHF 1.1 billion.

FarmaceutykiNovartis AG

↗

Novartis AG is a global healthcare company headquartered in Basel, Switzerland, dedicated to reimagining medicine to improve and extend people's lives. With a presence in approximately 120 countries, Novartis reached over 300 million patients worldwide in 2025. The company's portfolio includes innovative medicines in areas such as cardiovascular diseases, oncology, and rare genetic disorders, with a strong focus on advanced therapy platforms like cell and gene therapies, RNA therapeutics, and radioligand therapy. Novartis is committed to ethical practices, transparency, and expanding access to healthcare, aiming to deliver high-value medicines that address society's most pressing health challenges. Under the leadership of CEO Vasant Narasimhan since 2018, Novartis has experienced significant growth and innovation, solidifying its position as a leader in the pharmaceutical industry.

FarmaceutykiSandoz Group AG

↗

Sandoz Group AG, headquartered in Basel, Switzerland, is a leading global provider of generic pharmaceuticals and biosimilars. Established in 1886, the company specializes in the development, manufacturing, and marketing of a wide range of medicines across various therapeutic areas, including cardiovascular, oncology, infectious diseases, and immunology. Sandoz offers a comprehensive portfolio of active pharmaceutical ingredients and finished dosage forms, serving patients worldwide. With a strong commitment to quality and affordability, Sandoz plays a pivotal role in enhancing access to essential medicines, positioning itself as a key player in the global healthcare landscape.